NextSteps Capital
VC Fund
NextSteps Capital is a VC fund focused on Artificial Intelligence and Big Data. NextSteps Capital
- Total investments:
- 4
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries NextSteps Capital invests in
Stages NextSteps Capital invests in
Countries NextSteps Capital invests in
Investment Focus
Industry
- Artificial Intelligence 2 (50%)
- Big Data 1 (25%)
- Software 1 (25%)
- Analytics 1 (25%)
- CleanTech 1 (25%)
Stage
- Pre-Seed 1 (25%)
- Series A 1 (25%)
- Series B 1 (25%)
- Series C 1 (25%)
Country
- Italy 1 (25%)
- Ireland 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Founded in 2017, Deciphex aims to transform diagnostic workflows through AI-powered digital pathology to improve patient outcomes worldwide. Its two flagship platforms target distinct markets: Diagnexia connects global subspecialty pathologists for rapid diagnostics and backlog reduction, while Patholytix accelerates drug development throughoptimized preclinical safety assessments. By automating routine tasks, these platforms enable pathologists to focus on complex cases while delivering faster, more reliable diagnoses. Through this combination of AI innovation and clinical expertise, Deciphex is advancing both healthcare delivery and therapeutic development. | $32.1M / Series C / Jan 07, 2025 | |
|
|
Ganiga is an innovative startup in the Cleantech and Circular Economy sector, known for patenting and inventing a smart waste bin derived from materials recovered from decommissioned wind turbine blades from Enel Green Power. This integration of open innovation with the circular economy allows for autonomous waste separation using AI, generatingstatistics and data on waste types and quantities. The system notifies and plans optimized waste collection routes, reducing personnel costs and pollution associated with waste collection.Key Features of Ganiga's Solution:AI-Based Waste Sorting: The core of Ganiga's solution lies in its artificial intelligence technology, enabling automated waste recycling. Machine learning algorithms recognize and separate various waste materials, enhancing recycling process efficiency.Smart Waste Bins: Ganiga's intelligent waste bins are equipped with sensors and technology to identify and categorize waste as it is disposed of. Real-time data collection enables precise waste management and optimization.Data-Driven Waste Insights: The system gathers data on waste disposal patterns, providing detailed insights into consumer behavior, waste production trends, and recycling rates. This data-driven approach assists municipalities and businesses in making informed decisions.Customizable Waste Management: Ganiga's solution can be tailored to meet diverse waste management needs, whether in urban areas, public spaces, or corporate settings. The technology adapts to various environments and waste flows.Promoting Sustainability: Ganiga's solution encourages sustainable waste disposal practices, increasing recycling rates and diverting more materials from landfills, contributing to a greener and more environmentally friendly future.Seamless Integration: Ganiga's system seamlessly integrates with existing waste management infrastructure, simplifying adoption for municipalities and organizations without significant disruptions.Remote Monitoring: The solution's remote monitoring capabilities allow real-time tracking of waste bin statuses, optimizing waste collection routes and schedules, reducing costs, and minimizing environmental impact.This innovative startup's focus on AI-driven waste management and sustainability aligns with global efforts to address environmental challenges. Ganiga's commitment to reducing waste, enhancing recycling, and providing efficient waste management solutions positions it as a key player in shaping a more sustainable and environmentally conscious future. | $171.5K / Pre-Seed / Nov 06, 2023 | |
|
|
Founded in 2017, Deciphex aims to transform diagnostic workflows through AI-powered digital pathology to improve patient outcomes worldwide. Its two flagship platforms target distinct markets: Diagnexia connects global subspecialty pathologists for rapid diagnostics and backlog reduction, while Patholytix accelerates drug development throughoptimized preclinical safety assessments. By automating routine tasks, these platforms enable pathologists to focus on complex cases while delivering faster, more reliable diagnoses. Through this combination of AI innovation and clinical expertise, Deciphex is advancing both healthcare delivery and therapeutic development. | $11.5M / Series B / May 19, 2022 | |
|
|
Founded in 2017, Deciphex aims to transform diagnostic workflows through AI-powered digital pathology to improve patient outcomes worldwide. Its two flagship platforms target distinct markets: Diagnexia connects global subspecialty pathologists for rapid diagnostics and backlog reduction, while Patholytix accelerates drug development throughoptimized preclinical safety assessments. By automating routine tasks, these platforms enable pathologists to focus on complex cases while delivering faster, more reliable diagnoses. Through this combination of AI innovation and clinical expertise, Deciphex is advancing both healthcare delivery and therapeutic development. | $6.2M / Series A / Jul 16, 2020 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does NextSteps Capital invest in?
NextSteps Capital invests primarily in Artificial Intelligence, Big Data and Software startups, most often at Pre-Seed and Series A stage. Most of the 4 investments tracked by Shizune back companies in Italy. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did NextSteps Capital last invest?
The most recent investment recorded for NextSteps Capital closed in Jan 2025. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!